Clinical Trial Update: ST-2; a Non-invasive Fibrosis Marker for Chronic Hepatitis B

View source ↗

Summary

This entry provides an update on a clinical trial evaluating ST-2 as a non-invasive fibrosis marker for chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: Turkiye Yuksek Ihtisas Education and Research Hospital | Conditions: Sequela of Chronic Liver Disease | Status: UNKNOWN